AI In Cancer Diagnostics Market Size, Share & Industry Analysis, By Component (Software & Services), By Technology (Computer Vision, Machine Learning & Deep Learning, Natural Language Processing, & Others), By Modality (Liquid Biopsies, Imaging Diagnostics, Digital Pathology AI, Genomics and Biomarker Discovery, & Others), By Application (Screening support, Triage & Prioritization, Staging Support, & Others), By Deployment (Cloud-Based, On Premise, & Hybrid), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, & Others), By End User, and Regional Forecast, 2026-2034

Last Updated: April 03, 2026 | Format: PDF | Report ID: FBI115859

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 28.58% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Component, Technology, Modality, Application, Deployment, Cancer Type, End User, and Region
By Component	Software Services
By Technology	Computer Vision Machine Learning & Deep Learning Natural Language Processing Others
By Modality	Liquid Biopsies Imaging Diagnostics Digital Pathology AI Genomics and Biomarker Discovery Others
By Application	Screening support Triage & prioritization Staging support Quantification & Biomarker scoring Clinical Decision Support Others
By Deployment	Cloud-Based On Premise Hybrid
By Cancer Type	Breast Cancer Lung Cancer Colorectal Cancer Prostate Cancer Brain & Nervous System Cancers Others
By End User	Hospitals & ASCs Diagnostic Laboratories Research & Academic Institutes Others
By Region	North America (By Component, Technology, Modality, Application, Deployment, Cancer Type, End User, and Country) U.S. Canada Europe (By Component, Technology, Modality, Application, Deployment, Cancer Type, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Component, Technology, Modality, Application, Deployment, Cancer Type, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Component, Technology, Modality, Application, Deployment, Cancer Type, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Component, Technology, Modality, Application, Deployment, Cancer Type, End User, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa